GSK Stockmann

GSK Stockmann advised the LHI Group, based in Pullach, on extending the regulatory AIFM authorisation of LHI Kapitalverwaltungsgesellschaft mbH. LHI Kapitalverwaltungsgesellschaft mbH has been granted an extension to its financial portfolio management authorisation by the German Federal Financial Supervisory Authority (BaFin), and has increased its capital by two million euros to six million euros. This was accompanied by the merger of LHI Capital Management GmbH into LHI Kapitalverwaltungsgesellschaft mbH. This move enables the LHI Group, one of the most successful providers of investment and asset management services in Germany, to consolidate its investment business into a standalone entity, thereby strengthening its market position among institutional and professional investors. A GSK Stockmann team led by Munich partners Oliver Glück and Andreas Dimmling provided the LHI Group with comprehensive advice on regulatory, corporate and employment law issues in connection with the extension of the authorisation and the strategic realignment of the LHI Group. Advisers of the LHI Group at GSK Stockmann: Dr Oliver Glück (lead, Financial Services), Dr Dominik Stolz (Financial Services), Andreas Dimmling, Christina Lorf (both Corporate), Dr Philipp Kuhn, Raphaela Guderian (both Employment Law) ### [caption id="attachment_50988" align="alignnone" width="300"] GSK München[/caption] Contact: GSK STOCKMANN Dr Oliver Glück Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 33 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de

GSK Stockmann advised Art-Invest Real Estate on the sale of the Momenturm office building, located in Munich’s Werksviertel district, to Generali. The European commercial law firm has provided ongoing support to Art-Invest Real Estate with the project since the initial acquisition of the property. Art-Invest Real Estate has sold the Momenturm project to Generali Deutschland. The transaction was carried out by Generali Real Estate S.p.A. on behalf of Generali Deutschland. The existing approx. 11,000 sqm of office space in the building, located at Rosenheimer Strasse 139, just a stone’s throw away from Munich Ostbahnhof, is to be extended to around 28,000 sqm. Generali Deutschland plans to use the building as its new corporate headquarters, with 1,500 employees expected to be relocated there. A GSK Stockmann team led by Munich-based partner Dirk Brückner has been providing Art-Invest Real Estate with comprehensive support on this project since it first acquired the property back in 2019. The firm’s advice encompassed project structuring, project development and securing planning permission, as well as the sale to Generali. Art-Invest Real Estate is a long-standing client of GSK Stockmann. Most recently, the law firm advised the company on the acquisition of a hotel portfolio in 2024, which included properties in Berlin, Oberhausen, Koblenz and Frechen near Cologne. Other past projects include the acquisition of the Wangen office campus in Stuttgart and the Arnulfbogen in Munich, both in 2021, as well as the commercial property F150 on the Frankfurter Ring in Munich and the City-Passage in Wiesbaden, both in 2022. Advisers of Art-Invest Real Estate at GSK Stockmann: Dr Dirk Brückner (lead), Dr Mark Butt (both Real Estate Transactions & Investments), Stefan Dorn (Project Development), Stefan Wachsmuth (Tax), Katharina Feierabend (Real Estate Transactions & Investments); Associates: Sebastian Gerhards (Tax), Maximiliane Bartsch, Melanie Patrizia Seitz (both Real Estate Transactions & Investments), Leonie Lindenbuß (Project Development) GSK München Contact: GSK STOCKMANN Dr Dirk Brückner Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 71 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected]   GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de  

GSK Stockmann, working with a team of other firms including Troutman Pepper Locke, advised global digital infrastructure company Colt Technology Services on the sale of six of its data centres to NorthC, a data centre operator headquartered in the Netherlands. As part of the deal, Colt will also divest two of its other data centres in London to NorthC’s majority owner DWS Group. The eight data centres included in the transaction are in Amsterdam, Berlin, ‎Düsseldorf, Frankfurt, Hamburg and Munich, as well as the two in London. The data centres were part of the ‎assets Colt gained with its acquisition of Lumen EMEA in 2023. GSK Stockmann, working with Troutman Pepper Locke and a team of further local counsel and instructed by Nadine Ramasamy, Alex Galtieri and Annarita Spena of Colt, advised on the German real estate aspects of the deal and also on Colt’s ongoing partnership with NorthC. Colt’s future relationship with NorthC will include Colt retaining network equipment in the divested data centres as part of its global digital ‎infrastructure, which connects 32,000 buildings, spans more than 40 countries, reaches more than 275 ‎points of presence, and includes 10 subsea cable systems‎. The transaction is expected to close in summer 2025. [caption id="attachment_48296" align="alignnone" width="300"] GSK Berlin[/caption] Advisers of Colt at GSK Stockmann: Dr Olaf Schmechel (lead partner, Real Estate/Data Centres), Çağlayan Birkan (Real Estate), Sören Wolkenhauer (Energy), Dr Jörg Kahler (IP/IT), Dr Anna Charlotte Kümpers (Public Law) Contact: GSK STOCKMANN Dr Olaf Schmechel Mohrenstrasse 42 10117 Berlin T +49 30 203907 - 0 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de/en

GSK Stockmann provided comprehensive legal advice to the Arsipa Group on its acquisition of Mplus Managementgesellschaft zur Optimierung von Arbeitsbedingungen mbH. This strategic transaction will strengthen Arsipa’s occupational health and safety network across Germany and represents a further milestone in the expansion of its service portfolio. With around 85 employees and a highly regarded professional training academy, Mplus leads the market in occupational health and safety coordination services, and will expand the Arsipa Group’s local presence, particularly in the Rhineland. The current Mplus management team will remain on board to ensure the company’s continued successful development. The integration of Mplus brings comprehensive expertise in health and safety coordination, as well as certified training and further education programmes, into the Arsipa network. This will establish common quality, safety and knowledge transfer standards and enable the group to develop its services in targeted areas such as consultancy, prevention and training. Advisers of Arsipa at GSK Stockmann: Robert Korndörfer (lead, Partner, Corporate), Clara López Hernando (Senior Associate, Corporate), Maik Schäffer (Associate, Corporate), Stephan Wachsmuth (Local Partner, Tax), Nicole Deparade (Local Partner, Employment Law), Katrin Zukovskaja (Associate, Employment Law), Dr Martin Hossenfelder (Counsel, IP/IT), Dr Maximilian Schnebbe (Associate, Data Protection)

Starting on 3 July 2026, Nina Leonard will be joining GSK Stockmann, bringing valuable expertise in the data centre, battery storage and life sciences/pharmaceuticals sectors. In line with its strategy to expand its Corporate practice, GSK Stockmann has appointed Nina Leonard, a certified specialist in commercial and company law, as a new Equity Partner at the firm’s Munich office, effective from 3 July 2026. She joins the firm from Addleshaw Goddard, where her work focused on M&A and corporate law. Nina Leonard has over 24 years of experience in M&A advisory and specialises in complex, cross-border transactions. She has particular expertise in the data centre, battery storage, digital infrastructure and technology sectors. Her other areas of focus are the energy and life sciences/pharmaceuticals sectors – both areas in which GSK Stockmann is looking to expand strategically. Her expertise also extends to joint ventures and conflict and stakeholder management, particularly in the context of shareholder and post-M&A disputes. Alongside her legal expertise, Nina Leonard brings an entrepreneurial mindset and a wealth of experience in expanding law firms. For example, she successfully helped lead an international law firm’s entry into the German market as a founding partner, demonstrating her ability to cultivate lasting client relationships and teams. Her international background, including stints in London, Chicago and Beijing, as well as her many years of experience working with a British commercial law firm, makes her an ideal liaison for GSK Stockmann’s London office. Nina Leonard also has an outstanding academic track record, having co-edited and co-authored the leading commentary on the German Transformation Act (Semler/Stengel/Leonard, UmwG, currently in its sixth edition, C.H. Beck 2025) and published numerous academic articles on commercial and company law. Nina Leonard’s appointment is the latest in a series of strategic lateral hires at GSK Stockmann over the past two years, the most recent being Per Meyerdierks (data protection and technology), Dr Simon Spangler (antitrust) and Dr Bernd Graßl (stock corporation and capital markets law, corporate litigation and dispute resolution). Dr Katy Ritzmann, Head of Corporate at GSK Stockmann, comments: “Nina Leonard combines first-class M&A expertise with in-depth industry knowledge in key growth sectors, which complements the expertise of our colleagues working on projects in these areas perfectly. At the same time, her international network is a real asset for our cross-border advisory services. We are delighted to have her on board.” Nina Leonard adds: “GSK Stockmann combines an entrepreneurial approach with outstanding legal advice across all the practice areas relevant to my work. This creates an ideal environment for providing clients with strategic support. I am very much looking forward to building on these strengths together with the team.” ### Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de/en

GSK Stockmann has advised the shareholders of Beams Technology GmbH, Berlin, Germany, on their divestment to Insight Partners and Liberty Hall Capital Partners backed Comply365 Group. Comply365 is a leading provider of Operational Content Management, Safety Management and Training Management in the highly regulated industries of aviation, defense, rail and space. Beams has pioneered a Safety AI solution for the aviation industry to automate safety data processing and enable proactive, predictive risk management. The acquisition accelerates Comply365’s investment in the development of an industry-first, AI platform across operations, safety, and training management. More details can be found in the official deal notification. A GSK Stockmann team led by Berlin-based partner Robert Korndörfer advised the Beams shareholders on all legal and tax aspects of the divestment. GSK Stockmann’s M&A/private equity team regularly advises strategic investors and financial sponsors on domestic and cross-border buy-out and exit transactions. It consists of more than 50 lawyers working together seamlessly across our seven offices and all practice areas of GSK Stockmann. Advisers of the shareholders of Beams Technology GmbH at GSK Stockmann: Robert Korndörfer (lead, Partner, Corporate), Daniel Fehling (Partner, Corporate), Stephan Wachsmuth (Local Partner, Tax), Dominik Berka (Local Partner, Tax), Nicole Deparade (Local Partner, Employment), Dr Martin Hossenfelder (Counsel, IP/IT); Clara López Hernando (Senior Associate, Corporate), Raphaela Guderian (Associate, Employment), Katrin Zukovskaja (Associate, Employment) Other advisers: Contact: GSK STOCKMANN Robert Korndörfer Mohrenstraße 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] Willkie Farr & Gallagher for the Comply365 Group GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann provided comprehensive legal advice to Art-Invest Real Estate on a new long-term lease agreement with Süddeutscher Verlag for a large volume of office space in the SZ Tower in Munich. The SZ Tower is a landmark high-rise building located at Hultschiner Strasse 8 in eastern Munich. The building has a total area of approximately 21,490 square metres, with a lettable area of around 54,500 square metres GFA. Since its completion in 2008, the building has been used exclusively by the German media company Süddeutscher Verlag. The new lease represents a key milestone in the strategic transformation of the building into a modern, multi-tenant property. As part of the planned redesign, the SZ Tower will be modernised and adapted for new uses. Art-Invest Real Estate aims to update the property to meet the demands of the modern workplace by introducing a cutting-edge usage concept including shared amenities, such as modern conference and catering areas, fitness facilities and New Work spaces. GSK Stockmann provided expert advice to Art-Invest Real Estate, particularly regarding the legal structuring and negotiation of the new long-term lease agreement. This included guidance on the operating and utilisation concepts in a multi-tenant setting, aspects of tenancy law related to shared spaces, as well as investment law, tax requirements and sustainability. The firm’s advice also included the agreement of an interim phase for the remodelling of the property. “The new lease with Süddeutscher Verlag represents a successful combination of continuity and transformation. When structuring the contracts and conducting the negotiations, a balance had to be struck between the long-term requirements of an anchor tenant and the flexibility of a future multi-tenant concept, while also taking complex interdependencies with the construction measures during the remodelling, as well as ESG aspects into account. A well-balanced contractual framework is crucial for the integration of New Work concepts and shared spaces – from making the use of the space more flexible to ensuring governance-compliant management. This is precisely where our advice comes in. We are delighted to have supported Art-Invest Real Estate with this flagship project,” says Monique Franke, Partner for Real Estate Investments & Asset Management at GSK Stockmann. Advisers of Art-Invest Real Estate at GSK Stockmann: Monique Franke (lead, Real Estate Investments & Asset Management), Stephan Wachsmuth (Tax) and Bianca Luppert (Real Estate Investments & Asset Management) ### Contact: GSK STOCKMANN Monique Franke Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 661 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We provide comprehensive advice to domestic and international real estate investors, developers, owners and users at every stage of the real estate life cycle, from initial structuring and development to letting, operation and exit. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de [caption id="attachment_53828" align="alignnone" width="300"] GSK München[/caption]

GSK Stockmann advised GIEAG Immobilien AG on the financing for the construction of 218 new apartments in Karlsruhe via an international consortium of investors led by Crestline Investors, Inc. and Tite Street Capital. GIEAG Immobilien AG is moving ahead with the KWARTIER HOMES residential project in Karlsruhe’s Südstadt district. Comprising 218 apartments, expansive outdoor spaces, and three basement levels, including two for underground parking, KWARTIER HOMES is one of the most significant residential construction projects in the region. A GSK Stockmann team led by Munich partner Mechtild-Maria Siebke advised GIEAG on the project financing. Crestline Investors, together with its investment partner Tite Street Capital, secured full financing for the project via an international consortium of investors. Crestline Investors is a global institutional investment company with total assets under management of around USD 18 billion. Financial service provider Prime Capital also advised GIEAG in connection with the financing. Advisers of GIEAG Immobilien AG at GSK Stockmann: Dr Mechtild-Maria Siebke (lead, Finance), Andreas Dimmling (Corporate/Restructuring), Stephan Wachsmuth, Dominik Berka (both Tax); Associates: Marcel Alexander Buss (Finance), Theodor Lammich (Corporate/Restructuring). Contact: GSK STOCKMANN Dr Mechtild-Maria Siebke Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 667 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de

GSK Stockmann advised DZ HYP AG on the financing of the Upper West high-rise building in Berlin-Charlottenburg. The buyer is Schoeller Group GmbH, based in Pullach near Munich. Upper West is located directly on Berlin’s Breitscheidplatz, opposite Kaiser Wilhelm Memorial Church and just a stone’s throw from the city’s famous shopping boulevard, Kurfürstendamm. At around 120 metres high, it is one of the tallest buildings in Berlin. The building’s distinctive glass and steel façade makes it a striking part of the city’s skyline. The building also meets high standards in terms of urban development and sustainability. Upper West combines office and retail space, as well as a Motel One flagship hotel with 582 rooms over 19 floors. The building is DGNB Gold & LEED Platinum certified. A GSK Stockmann team led by Munich partner Alma Franke advised DZ HYP on financing the purchase transaction. Advisers of DZ HYP AG at GSK Stockmann: Dr Alma Franke (lead), Dr Mechtild-Maria Siebke, Marcel Buss, Beatrice Christina Dörr (all finance), Robert Korndörfer, Dr Raoul Kreide, Matti Kamer (both corporate), Stefan Schlapka (real estate law/hospitality), Andreas Heinzmann, Hawa Mahamoud, Eva Jean (corporate/finance, Luxembourg)

GSK Stockmann has provided comprehensive legal advice to Redevco on the financing of two logistics developments near Frankfurt and Karlsruhe, addressing both German and Luxembourg law aspects. Redevco has extended a EUR 67 million loan to support the acquisition and development of the projects, which are being undertaken by a joint venture between Invesco Real Estate and Propel Industrial. Together, the projects comprise approximately 63,000 m² of logistics space. The transaction represents the second investment of Redevco’s real estate credit platform, launched in early 2025 to deploy balance sheet and co-investment partner capital across senior, whole-loan and mezzanine strategies in key European markets and asset classes. GSK Stockmann’s multidisciplinary team advised Redevco on all legal aspects of the financing. In the UK, Redevco was advised by Stephenson Harwood LLP. Advisors of Redevco at GSK Stockmann: Dr Alma Franke (lead, Finance), Dr Mechtild-Maria Siebke (Finance), Andreas Heinzmann (Finance), Dominik Berka (Tax), Marcel Buss (Finance), Hawa Mahamoud (Finance), Eva Jean (Finance) Contact: GSK STOCKMANN Dr Alma Franke Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 667 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de

GSK Stockmann advised Catella Investment Management GmbH on the acquisition of two developments in the “Liesel Quartier” in Göttingen. The two planned residential buildings, including a day-care centre, in the “Liesel Quartier” development in Göttingen were acquired on behalf of an individual client. The seller is WERTGRUND Wohnpartner GmbH, a joint venture between Wertgrund Immobilien AG and Bautra GmbH. WERTGRUND Wohnpartner is also acting as the project developer for the new neighbourhood. The Liesel Quartier development will involve the construction of around 570 apartments with a total living space of 44,000 square metres in several phases on a site covering around 37,000 square metres. Approximately 40% of the apartments will be subsidised, offered at reduced rates or subject to rent controls. Construction is set to begin in December 2025, with completion scheduled for 2027. The transaction concerns the acquisition of buildings H40 and H50 on the southern part of the construction site. They comprise a total of 118 privately financed apartments, ranging in size from 41 to 86 square metres, with a total rental area of 7,810 square metres, as well as an underground parking garage. The planned five-storey buildings will be constructed to the German Efficiency House 40 (EH 40) standard and will be connected to the district heating network operated by Göttingen’s municipal utility company. Advisers of Catella Investment Management GmbH at GSK Stockmann: Jan Kramer (lead, Real Estate Transactions & Project Development), Sascha Zentis (Real Estate Transactions & Investments), Kristina Marx, LLM (Public Law), Anna-Lena Diedrich (Real Estate), Dr Metin Tatu (Real Estate Transactions & Project Development) Contact: GSK STOCKMANN Jan Kramer Bockenheimer Landstr. 24 60323 Frankfurt am Main T +49 69 710003 - 128 F +49 69 710003-144 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

Legalcommunity – one of the largest legal media in Southern Europe for business lawyers, tax lawyers and accountants – awarded GSK Stockmann in the category “Italian Desk” at the Legalcommunity Finance Awards 2025. The Legalcommunity Awards are widely regarded as one of the most important Italian awards in the sector, recognizing excellence in the legal market. Valerio Scollo, Partner at GSK Stockmann and co-head of the GSK Desk Italy, says: “We are thrilled that our work is recognized by the Legalcommunity Finance Awards 2025 in the category “Italian Desk”. Winning the award underlines GSK Stockmann’s ongoing growth and development of the firm’s international activities, in particular of the GSK Desk Italy and the Finance practice.” Legalcommunity Publishing Group explains the award: “The European law firm boasts a strong team of 15 lawyers dedicated to the Italian desk, who have handled numerous cross-border transactions. Among these, their assistance to a well-known Italian telecommunications operator in a multi-billion-euro deal stands out.” In 2022, GSK Stockmann was named “Best Practice Italian Desk” at the Legalcommunity Real Estate Awards; the full list of winners of the Legalcommunity Finance Awards 2025 is available here.  

Under the theme “A Journey”, the Luxembourg office of GSK Stockmann celebrated its 10th anniversary with a recent event in its Luxembourg office attended by more than 220 guests, including ministers, excellencies and ambassadors as well as clients, business partners, colleagues, and friends from Luxembourg and abroad. Luxembourg based partner Dr. Marcus Peter opened the event with a welcoming statement and led through the evening. The co-managing partners of GSK Stockmann are Dr. Oliver Glück and Dr. Justus Jansen; in their speech they reflected on a decade of collaboration, achievement and growth of the Luxembourg office. Following an inspiring speech by Luxembourg's Minister of Justice, Elisabeth Margue, about the Grand Duchy's legal and judicial system, Luxair CEO Gilles Feith gave a keynote address about Luxembourg as a hub, introducing the company's collaboration with Luxair alongside Luxembourg artist Sumo. Daniel Mac Lloyd, a Luxembourg artist, discovered insightful remarks about GSK Stockmann's impact on Luxembourg’s art scene; his hand-painted gin bottles garnered significant attention. The premiere of the firm’s new image video, showcasing milestones of the past decade and introducing intriguing upcoming projects, served as the program’s high point. A concert by the talented violinists Eleanna Stratou and Leo Strelle of the Luxembourg Philharmonic Academy concluded the official part of the event – along with the birthday cake being presented and cut by the three founding partners of the Luxembourg office, Dr. Marcus Peter, Andreas Heinzmann and Dr. Philipp Mössner. The evening served as a reflection of GSK Stockmann’s continuous journey, its commitment to Luxembourg and its vision for the future. Following the evening’s theme, it is an ongoing journey that will continue above and beyond. Always! Since opening its doors in 2016, the Luxembourg office of GSK Stockmann has grown substantially, both, in size and identity – and alongside its clients, business partners, colleagues and teams as well as in the markets. It has established itself as a hub for complex cross-border work, now comprising a team of more than 60. The office achieved standout growth and accomplishments throughout the recent years, including being named “Law Firm of the Year – Benelux” at the prestigious The Lawyer European Awards. Over the past decade, GSK Stockmann in Luxembourg has advised on many of Luxembourg’s most significant, complex, cross-border deals reflecting the continued growth and breadth of a multi-disciplinary team and quality of client service. Selected quotes about 10 years of GSK Stockmann in Luxembourg: “A decade ago, we set out with a pioneering vision: to provide our clients with seamless, qualitatively top cross-border solutions from one firm. What began with a small team has grown into a powerhouse of more than 60 people representing over 15 nationalities. This success belongs to our loyal clients, our dedicated team, and our founding partners who steered the ship through every challenge. As we celebrate this milestone, we look forward to the next chapter – continuing to be a trusted advisor in the context of the upcoming transformation for our clients’ international ambitions across Europe.” – Dr. Oliver Glück | Co-Managing Partner | GSK Stockmann. “For the past ten years, GSK Stockmann in Luxembourg has advised clients on the transactions and regulatory challenges that shape this market. None of this would have been possible without the trust our clients have placed in us. It is their confidence in our work that has driven us to grow, to improve, and to always deliver the highest standard of legal counsel.” – Dr. Justus Jansen | Co-Managing Partner | GSK Stockmann. “Ten years of GSK Stockmann in Luxembourg have been an incredible success — built through hard work, but also with a lot of fun along the way! I would like to express my gratitude to our teams, our clients and our GSK colleagues in Germany, all of whom have contributed to this success. I look forward to continuing this journey with GSK Stockmann in Luxembourg as a great law firm producing high-quality work for our clients, always with a positive attitude and never forgetting the human and social touch that is necessary to make business successful.” – Dr. Marcus Peter | Partner | GSK Stockmann. “We are grateful to all clients, lawyers and colleagues who supported the journey of GSK Stockmann in Luxembourg – onwards and upwards to the next 10 years.” – Andreas Heinzmann | Partner | GSK Stockmann “Ten years ago, three partners and a deeply committed team opened the doors of GSK Stockmann in Luxembourg. Today, more than 60 professionals call this office home — not because the hours demand it, but because the culture, the people and the quality of what we do together make them want to be here. What makes me proudest is not the growth itself but how we grew — organically, through talent nurtured in-house, without ever imposing a culture of billable hours pressure and without ever compromising on who we are. It works.” – Dr. Philipp Mössner | Partner | GSK Stockmann. --- Underpinning the firm’s approach to corporate social responsibility, GSK Stockmann is dedicated to making a positive contribution to its environment and would like to further support the work of the Luxembourg Philharmonic Academy with a donation. The Luxembourg Philharmonic Academy was founded in 2021 and GSK Stockmann has supported the Academy as sponsors since its very beginning. Created to train and support the next generation of orchestra musicians, the Luxembourg Philharmonic’s signature Academy offers young musicians from around the world two years of intensive orchestral training alongside the members of the Luxembourg Philharmonic — through concerts, tours, recordings and intensive coaching at the highest level. If you are interested to find out more about, please do not hesitate to contact us: [email protected] --- To find out more about our journey through the past 10 years and about our recent event, take a moment to flip through our booklet, photos and videos: Press release_Celebrating 10 years of GSK Stockmann in Luxembourg

In another significant strategic move, GSK Stockmann welcomes Simon Spangler as a new partner as of 1 August 2025. This new addition underlines the firm’s leading position in commercial law and transformation issues and will enhance its range of advisory expertise for national and international clients and projects. Dr Simon Spangler is a renowned expert in German and European antitrust law as well as in the areas of compliance and ESG. He specialises in providing antitrust and distribution law advice to companies in the technology, consumer goods and life sciences sectors. He also provides comprehensive advice on issues relating to the platform economy, private enforcement issues and merger control proceedings at the national and international level. In addition, he has many years of experience in related compliance issues, particularly in ESG compliance and internal investigations, as well as in state aid and subsidy law. Simon Spangler’s wealth of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s Corporate team, where he will work closely with the firm’s IT and AI specialists to set new benchmarks in the field of digital economy and AI solutions and help to accelerate the firm’s growth. Simon Spangler is joining GSK Stockmann from Oppenhoff & Partner, where he has worked in the field of antitrust and state aid law since 2013, becoming a partner in January 2019. He will be accompanied by his colleague Renée Eckruth, who will join GSK Stockmann as a Senior Associate. “We are delighted to be welcoming a recognised expert like Simon Spangler to our team. His expertise and network will be a great asset and support the strategic development of our Corporate team. The addition of this new team ensures that we are now in an even stronger position to continue providing our clients with the best possible support with all kinds of complex matters in the future,” says Dr Justus Jansen, Managing Partner at GSK Stockmann. “Simon Spangler’s impressive range of expertise will be a valuable addition to our Corporate team in Germany, Luxembourg and London. Thanks to his extensive expertise in antitrust law and compliance advice, we can now offer the full scope of services in this area. This enables us to provide real added value to our clients and explore additional areas of advice with significant business development potential. His knowledge and many years of experience will help to strengthen and enhance our Corporate team in the long term,” comments Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division. Simon Spangler also sees great potential in his new role at GSK Stockmann: “I am very pleased to be able to put my expertise to good use at GSK Stockmann – especially in dynamic, future-oriented fields such as digitalisation and ESG. Together with the experienced team at GSK Stockmann, I am confident that I can provide our clients with bespoke, forward-thinking advice.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised the fintech company Eleving Group on the completion of the largest offer of shares by way of an initial public offering (IPO) of a privately held company in Latvia and subsequent listing and trading of the offered shares on the Nasdaq Baltic Main List and Frankfurt Stock Exchange’s regulated market Prime Standard. With the IPO, Eleving Group aims to offer investors an opportunity to invest in one of the fastest growing, Baltic-headquartered, and Luxembourg-domiciled fintech companies operating in vehicle and consumer financing segments across 16 markets and three continents. The GSK Stockmann team from Luxembourg, led by Andreas Heinzmann, provided comprehensive legal advice to Eleving including the drafting of the prospectus, the share capital increase and the dual listing of the shares on the Frankfurt Stock Exchange´s regulated market and on the Nasdaq Baltic main list. Eleving Group has driven innovation in financial technology around the world since its foundation in Latvia in 2012. As of today, the group operates in 16 markets and three continents, encouraging financial inclusion and upward social mobility in underserved communities around the globe. Eleving Group has developed a multi-brand portfolio for its vehicle and consumer finance business lines, with around 2/3 of the portfolio comprising secured vehicle loans and mobility products, with Mogo as the leading brand, and around 1/3 of the portfolio including unsecured consumer finance products, with Kredo and Tigo as the segment’s flagship brands. Currently, 55 % of the group’s portfolio is located in Europe, 32 % in Africa, and 13 % in the rest of the world. The following GSK Stockmann team advised Eleving: Andreas Heinzmann (Lead Partner – Banking, Finance and Capital Markets | Luxembourg), Hawa Mahamoud (Senior Associate – Banking, Finance and Capital Markets | Luxembourg), Katharina Schramm (Senior Associate – Banking, Finance and Capital Markets | Luxembourg), Eva Jean (Associate – Banking, Finance and Capital Markets | Luxembourg), Chara Papagiannidi (Senior Associate – Corporate and Capital Markets | Luxembourg), Dr. Alexander Thomas (Partner – Corporate and Capital Markets | Munich), Anna Gassner (Partner – Corporate and M&A | Luxembourg), Mathilde Ostertag (Partner –Tax | Luxembourg), Adrien Kleinschmidt (Senior Associate – Tax | Luxembourg), Dominik Berka (Local Partner – Tax | Frankfurt)

Commercial law firm GSK Stockmann successfully advised Pembroke Real Estate on the acquisition of a high-profile development site located on Alramstrasse in Munich’s Sendling district. The highly complex and time-sensitive transaction involved not only the conclusion of a share and asset deal, but also numerous accompanying agreements and negotiations with multiple parties. The acquisition marks Pembroke Real Estate’s first foray into the German real estate market. The international real estate firm has already acquired multiple high-end commercial properties in Munich and Hamburg. An experienced GSK Stockmann team led by partners Volker Hofstetter (Real Estate, Frankfurt) and Marcel Vietor (Corporate, Munich) provided Pembroke Real Estate with comprehensive legal advice to ensure a smooth transaction process. The successful completion of this complex transaction in such a short timeframe is a testament to the firm’s 360-degree advisory approach, which creates added value for its clients through interdisciplinary and innovative solutions and an in-depth understanding of the legal and economic requirements for these kinds of transactions, even during challenging market phases. Advisers of Pembroke Real Estate at GSK Stockmann: Volker Hofstetter (lead, Partner, Real Estate), Dr Marcel Vietor (lead, Partner, Corporate); Andreas Dimmling (Partner, Insolvency & Restructuring); Dr Alma Franke (Partner, Finance); Dr Maximilian Schilling (Partner, Construction Law); Dr Mark Butt (Partner, Public & Planning Law); Dr Timo Bernau (Partner, Regulatory); Jan Kramer (Local Partner, Construction Law); Dr Katharina Odermatt (Local Partner, Real Estate); Felix Bergfort (Local Partner, Real Estate); Dr Mechthild Maria Siebke (Local Partner, Finance); Dominik Berka (Local Partner, Tax); Dr Uta Birk, David Hansen, Claudia Maria Laszuk, Karolin Streser (Associates, Real Estate); Andrea Nowak (Associate, Corporate); Marcel Buss (Associate, Finance); Iryna Stefak (Associate, Construction Law); Leonie Lindenbuß (Associate, Public & Planning Law); Dr Martin Freytag and Nicole Habersetzer (Associates, Regulatory). ### Contact: GSK STOCKMANN Volker Hofstetter Bockenheimer Landstr. 24 60323 Frankfurt am Main T +49 69 710003 - 137 F +49 69 710003-144 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

At the prestigious The Lawyer European Awards 2024 in London, GSK Stockmann has been named “Law Firm of the Year for Benelux”. In addition, the firm received the recognition “commended” in the category “Law Firm of the Year for Germany” and was “shortlisted” in the category “European Law Firm of the Year”. The Lawyer European Awards are aimed at leading law firms based within Europe. Each category has specific criteria and the awards are open to independent law firms headquartered in Europe and global firms working within the European market. The awards incorporate country and region-specific awards categories. They were the first Awards established to celebrate excellence across the European legal market. The awards jury explains the decision behind naming GSK Stockmann “Law firm of the Year for Benelux” with the following statement: “The winning firm in this category distinguished itself through its impressive client list and an emphasis on strategic growth and international reach. Showcasing a balanced performance with notable ESG and D&I efforts, together with a strong focus on key markets such as investment funds and real estate finance.” “Congratulations to all of this year’s winners, as well as to those who were commended or shortlisted. A sincere thanks goes to all clients and peers for their continued trust and endorsements. We are proud of our strengthened international visibility and to have such excellent teams across our offices in Luxembourg, London and Germany. Many thanks to all at GSK Stockmann for their hard work and dedication: We will continue to write our success story”, comments Dr. Oliver Glück, Co-Managing Partner at GSK Stockmann in Germany. Andreas Heinzmann, International Partner at GSK Stockmann in Luxembourg, adds: “We are delighted about the firm’s results at the awards ceremony in London. Winning the award underlines the strong local presence and the ongoing strategic growth and development of GSK Stockmann coupled with a clear focus on cross-border activities across the firm’s offices in Germany, Luxembourg and London.” This year, a total of 27 awards were handed out over the course of the evening. Winners were named in a range of categories focused on particular jurisdictions, practice groups, initiatives as well as individual awards for the year’s outstanding general counsel or managing partner. Further information about this year’s The Lawyer European Awards and the full list of winners is available here.

Labour and social security law expert Daniel Nerl has joined GSK Stockmann’s team in Luxembourg as local partner, where he will develop the firm’s new practice in that area. He joins from leading independent business and litigation law firm Kleyr Grasso – together with his Associate Julie Tisserand – and will work closely together with Counsel Marie-Therese Wich. Daniel Nerl has extensive experience in the fields of labour and social security matters. He has been advising clients since 2011 on the entire spectrum of human resources matters by offering a full-service approach from advisory on day-to-day matters (including on- and offboarding, due diligences, general corporate support, etc.) to litigation. In addition, he has been a lecturer for training organisms on HR matters for over 10 years. Daniel Nerl studied in France in Bordeaux and Paris at the Sorbonne and was admitted to the bar in Luxembourg in 2011; he is member of ELSA asbl – Employment Law Specialist Association Luxembourg. “We are pleased to welcome Daniel Nerl and Julie Tisserand to our team. Their strong experience in the field of labour law and litigation as well as their deep expertise of the Luxembourg market will benefit our international client base”, comments Andreas Heinzmann, Partner at GSK Stockmann in Luxembourg. “We are looking forward to working with the new team members who will further strengthen our international capabilities in labour law and litigation. We wish them a great start at GSK Stockmann”, adds Dr. Oliver Glück, Co-Managing Partner at GSK Stockmann. “I am thrilled to join GSK Stockmann in Luxembourg, together with my long-term colleague Julie Tisserand, and am looking forward to working with a strong team on challenging and complex projects”, says Daniel Nerl. The office of GSK Stockmann in Luxembourg opened in 2016 with four partners and has since grown to a team of more than 30 fee earners focussing on the field of Banking & Finance, Capital Markets, Corporate and M&A, Private Equity, Investment Funds, Real Estate, Regulatory, Insurance, and Tax. Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised the Arsipa Group on its acquisition of Dr. med. Wörner Medizin-Diagnostik-Sicherheit GmbH (MDS Wörner). MDS Wörner will merge with ascatu GmbH, another Arsipa Group company. This will enable ascatu to secure the succession of an established occupational health practice in the Rhine-Neckar metropolitan region, ensuring continued care for its long-standing customers in the industrial, trade and service sectors. A GSK Stockmann team led by Berlin-based partner Robert Korndörfer provided the Arsipa Group with comprehensive legal advice on the transaction. The merger will enable the occupational healthcare provider ascatu to expand the scope of its care in the Rhine-Neckar region and support even more local companies in future. Founded almost 20 years ago in Eppelheim, MDS Wörner offers a wide range of occupational healthcare services in Heidelberg and the surrounding area. As part of the merger, the entire MDS Wörner team of experienced specialist doctors and medical staff will be transferred to ascatu GmbH. The Arsipa Group is a group of companies specialising in health, safety and well-being in the workplace. With over 1,100 employees across more than 70 locations in Germany and Austria, the Arsipa Group supports around 35,000 companies. In recent months, GSK Stockmann has advised the Arsipa Group on various transactions in the healthcare sector. Advisers of ascatu at GSK Stockmann: Robert Korndörfer (lead, Partner, Corporate), Nicole Deparade (Local Partner, Employment Law), Dr Martin Hossenfelder (Counsel, Data Protection), Clara López Hernando (Senior Associate, Corporate), Associates: Ricarda Jost (Corporate), Katrin Zukovskaja (Employment Law), Dr Maximilian Schnebbe (Associate, Data Protection) ### Contact: GSK STOCKMANN Robert Korndörfer Anton-Wilhelm-Amo-Str. 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

Based on the successful partnership agreement between GSK Stockmann and the Brexit Institute since 2020, GSK Stockmann will continue to sponsor the activities of the Institute in the field of European affairs for three more years – until 2027. The partnership agreement was extended in light of a number of important developments in relation to EU financial and economic affairs. Valerio Scollo, Partner at GSK Stockmann in Luxembourg, comments: “GSK Stockmann is pleased about the extension of the partnership agreement with the Brexit Institute providing insights on the future of the European Union. Situated in the heart of Europe, the Luxembourg office of GSK Stockmann is ideally positioned to support the activities of the Brexit Institute.” Professor Federico Fabbrini, Full Professor of EU Law and Founding Director of the Brexit Institute says: “As the Brexit Institute steadily expands its remit – as visible with the recent establishment of the Dublin European Law Institute – and secures new EU research projects – notably a major Jean Monnet Network – we are delighted to continue the fruitful and enriching cooperation with a leading European law firm like GSK Stockmann.” Given the multifaceted legal, political and economic implications of Brexit, Dublin City University (DCU) has established the Brexit Institute with the aim to explore how Brexit impacts on government, business and society at large. The DCU Brexit Institute operates as a hub and a magnet for the analysis of Brexit, both from an academic and a policy perspective. Through the organization of regular events the Brexit Institute provides a leading platform to document and debate developments in the relations between the UK and the EU. GSK Stockmann is a leading European law firm with offices in Germany, Luxembourg and the UK. Since its opening in 2016, the Luxembourg office of GSK Stockmann has grown significantly. With Luxembourg being situated at the centre of Europe and being the home of numerous EU institutions, GSK Stockmann is the trusted advisor of leading financial institutions, asset managers, private equity houses, insurance companies, corporates and FinTech companies, with both a local and international reach.

GSK Stockmann advises Catella Investment Management GmbH (CIM) and its investment management platform Catella Real Estate AG on the acquisition of a newly built residential complex with 37 units in Berlin. The residential complex was acquired on behalf of the public real estate AIF Catella European Residential (CER). The seller is OTTO WULFF Projektentwicklung GmbH. The six-storey building comprises 37 apartments with a total living space of approximately 3,000 square metres, as well as an underground parking garage with 21 parking spaces. The property also offers 106 bicycle parking spaces. The building meets the EH 55 energy efficiency standard (KfW 55) and is connected to the local district heating network. A photovoltaic system on the roof covers part of the building’s energy requirements. Around half of the apartments are accessible for disabled tenants. The underground parking spaces are pre-fitted with cabling for the future installation of electric vehicle charging points. Completion of the residential complex is scheduled for the end of 2025. Advisers of Catella Investment Management GmbH/Catella Real Estate AG at GSK Stockmann: Jan Kramer (lead, Real Estate Transactions & Project Development), Sascha Zentis (Real Estate Transactions & Investments), Kristina Marx, LLM (Public Law), Dominik Berka (Tax), Dr Metin Tatu (Real Estate Transactions & Project Development)

GSK Stockmann advised Technologiepark Heidelberg II GmbH & Co. KG, a subsidiary of Sparkasse Heidelberg, on the sale of three research and laboratory properties to GalCap Europe. The approximately 13,800 square metres of rental space are located in the “Im Neuenheimer Feld” technology park in Heidelberg. A GSK Stockmann team led by partner Dr Martin Prothmann provided Technologiepark Heidelberg II GmbH & Co. KG, a subsidiary of savings bank Sparkasse Heidelberg, with comprehensive advice on the sale. The Heidelberg Technology Park is located in the immediate vicinity of the University Hospital Heidelberg and the German Cancer Research Centre (DKFZ), placing it at the heart of one of Europe’s foremost life science clusters. The properties are fully let to companies and research institutions from the biotechnology, pharmaceutical and diagnostics sectors. The site is one of Germany’s central life science hubs, fostering close collaboration between university research, clinical applications and private companies. For the buyer, GalCap Europe, the transaction marks its entry into the German life science real estate market and the expansion of its portfolio, which currently comprises four properties in Austria with a market value of around EUR 100 million. Based in Vienna, GalCap Europe is a real estate asset and investment manager focusing on Austria and Central Europe. Advisers of the seller at GSK Stockmann: Dr Martin Prothmann (lead, Real Estate Transactions & Investments), Jakob Haddad (Real Estate Transactions & Investments), Pascal Franke (Real Estate Transactions & Investments), Stephan Wachsmuth (Tax) ### Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann advised VIVAO Investment & Assetmanagement GmbH, based in Munich, on the long-term re-letting of the BOA VISTA office building in Hamburg.VIVAO has let around 3,300 square metres of office space, as well as storage space and underground parking spaces, in the BOA VISTA office building in Hamburg to FRANK Immobilien und Lebensformate GmbH. FRANK will move into the premises from January 2027 and use them as its new headquarters. Katharina Feierabend, a Local Partner at GSK Stockmann in Munich, advised VIVAO on negotiating and drafting the lease agreement.Completed in 2015, the BOA VISTA office building is situated in a prominent location in Hamburg’s Portuguese Quarter, offering impressive views of the River Elbe, the Elbphilharmonie and HafenCity. Thanks to its modern architectural design, the property is one of the most striking office buildings in the Port of Hamburg and offers flexible layout options and energy-efficient building services. VIVAO provides comprehensive asset management services for the property. Securing FRANK Immobilien und Lebensformate as a tenant represents a major success for the property.Advisers of VIVAO Investment & Assetmanagement GmbH at GSK Stockmann:Katharina Feierabend (Real Estate Asset Management)

European commercial law firm GSK Stockmann provided the Arsipa Group, backed by Warburg Pincus, with comprehensive legal advice on its acquisition of the Munich-based occupational healthcare provider Betriebsmedizin-23 GmbH. This represents a further step in Arsipa’s strategic expansion in the field of occupational medicine and also strengthens its presence in Bavaria. The acquisition provides a long-term succession solution for the well-established occupational medicine practice Betriebsmedizin-23, ensuring continuity of service for its clients in the greater Munich area. Under the management of Dr Markus Heyenbrock, the practice provides services primarily to small and medium-sized companies in the industrial, service, healthcare and public sectors. Its scope of services includes standard occupational health services, medical check-ups, vaccinations, advice on risk assessments and mental stress, as well as workplace integration management and occupational health and safety training. Following the acquisition, Betriebsmedizin-23 will benefit from the digital management solutions offered by the Arsipa Group, which will enable it to optimise its administrative processes and ultimately improve medical care. The acquisition takes the Arsipa Group’s network to over 60 locations serving more than 22,000 companies. A team led by Berlin-based partner Robert Korndörfer advised the Arispa Group on the acquisition. GSK Stockmann has a proven track record in providing expert advice on transactions in the healthcare sector, having previously advised Arsipa on its acquisition of the occupational healthcare provider Betriebsärzte Allgäu. Advisers of Arsipa at GSK Stockmann: Robert Korndörfer (lead, Corporate), Clara López Hernando (Corporate), Stephan Wachsmuth (Tax), Nicole Deparade (Employment Law), Katrin Zukovskaja (Employment Law), Dr Martin Hossenfelder (IP/IT), Dr Maximilian Schnebbe (Data Protection) Contact: GSK STOCKMANN Robert Korndörfer Anton-Wilhelm-Amo-Str. 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann provided ongoing advice to Merz Objektbau GmbH throughout the project, as well as on the sale by way of a forward deal of a residential development already under construction on Kleebühlweg in Heidenheim-Nord. The buyer, VALUES Real Estate, intends to incorporate the project into the newly launched “VALUES Impact Living” fund for subsidised housing (special AIF in accordance with Art. 9 SFDR). The new residential quarter will comprise around 4,380 sqm of rental space, containing a total of 61 one- to five-room flats and the corresponding number of parking spaces. Completion is scheduled for the second quarter of 2026. The project will be constructed using a serial timber hybrid method and has been designed to meet the KfW 40 energy efficiency standard. All flats will be wheelchair accessible and have balconies or terraces and fitted kitchens. The focus is on providing housing for middle-class tenants who are eligible for subsidised housing (WBS). The starting rent is EUR 8.50 per square metre, around 40% below the comparative rent for the local area. VALUES Real Estate plans to integrate the project into its ESG-focused investment strategy, which prioritises projects with a strong social and environmental impact. Advisers of Merz Objektbau at GSK Stockmann: Dr Olaf Schmechel (lead, Real Estate Investments & Asset Management), Çağlayan Birkan (Real Estate Investments & Asset Management), Frank-Florian Seifert (Public Law), Dr Oda Wedemeyer (Construction Law), Rebecca Comtesse (Financing/Subsidies) GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de [caption id="attachment_52618" align="alignnone" width="300"] GSK Berlin[/caption]

GSK Stockmann advised the Arsipa Group on the acquisition of Betriebsärzte Allgäu, a well-established occupational healthcare provider based in Kempten. This acquisition will expand Arsipa’s presence in one of the strongest economic regions in southern Germany. A GSK Stockmann team led by Berlin partner Robert Korndörfer provided the Arsipa Group with comprehensive legal advice on the merger with Betriebsärzte Allgäu. The merger was carried out as part of an orderly succession plan, with three of the four partner doctors gradually stepping down from their senior management positions. They will, however, continue to work for the company as medical practitioners. The Arsipa Group is a Warburg Pincus portfolio company specialising in occupational medicine, occupational safety, occupational psychology and environmental protection. It has around 750 employees across more than 50 locations in Germany and Austria and provides services to over 20,000 companies. Betriebsärzte Allgäu is a partnership company founded in 2015 and based in Kempten. The team looks after more than 600 companies in the Allgäu region, focusing on occupational medicine while also providing complementary services in specialised areas such as traffic medicine, allergology and holiday/travel medicine. The practice primarily works with companies in the transport, logistics and industrial sectors, as well as with public sector organisations such as the German Armed Forces. Advisers of Arsipa at GSK Stockmann: Robert Korndörfer (lead, Partner, Corporate), Stephan Wachsmuth (Local Partner, Tax), Nicole Deparade (Local Partner, Employment Law), Dr Martin Hossenfelder (Counsel, IP/IT), Clara López Hernando (Senior Associate, Corporate), Katrin Zukovskaja (Associate, Employment Law), Dr Maximilian Schnebbe (Associate, Data Protection) ### Contact: GSK STOCKMANN Robert Korndörfer Anton-Wilhelm-Amo-Str. 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann in Luxembourg was again recognized as Great Place to Work® for December 2024-December 2025 based on an extensive anonymous online survey with 69 questions conducted by the Great Place to Work® Institute. As a result of the study, the trust index shows that 80 % of the team members say that GSK Stockmann in Luxembourg is a Great Place to Work®. As the global authority on workplace culture, Great Place To Work® brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List. The Great Place To Work® Certification™ is the most definitive “employer-of-choice” recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified. “We are proud to earn for the third time The Great Place to Work® Certification™ which is based on the positive feedback from our lawyers and employees alike and shows that our firm is a true collaborative and positive environment that emphasizes the importance of wellbeing. This recognition underlines our successful development combined with our strong focus on firm culture and values. Therefore, we would like to thank our entire team for contributing to establish a Great Place to Work®”, says Dr. Manuel Fernandez, Partner in charge of HR at GSK Stockmann in Luxembourg. Further information regarding the Great Place to Work® certification can be found on the following website: https://www.greatplacetowork.lu/fr/certification/profils/gsk-stockmann

Christine Ström joined GSK Stockmann as the firm’s new Strategic Communications Manager as of 1 January 2026. She will be responsible for managing the law firm’s corporate communications team and overseeing the strategic direction and further development of the firm’s communications activities. Christine Ström previously worked at GSK Stockmann as PR Manager from 2019 to 2022. During this time, she played a significant role in developing and professionalising the firm’s PR and communications structures. Having held PR and marketing roles in China, the USA and Germany, most recently as Senior PR Manager at the corporate law firm GÖRG, she is now returning to GSK Stockmann with a wealth of experience and international expertise. Christine has almost 20 years of experience in PR, marketing and strategic communications, with particular expertise in the positioning of corporate law firms, media and crisis communications, as well as the development and management of communications teams. “We are delighted to welcome Christine Ström back to our team. Her many years of experience in strategic communications and marketing, combined with her in-depth knowledge of our firm, will be a vital asset in further developing our corporate communications,” says Dr Justus Jansen, Managing Partner at GSK Stockmann. In appointing Christine Ström, GSK Stockmann has acquired an experienced communications expert who will further strengthen the firm’s strategic positioning. Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

GSK Stockmann provided Nyoo Real Estate GmbH, a subsidiary of the Instone Group, a residential developer operating throughout Germany, with legal advice on the acquisition of an approximately 9,700 sqm site near Stuttgart. nyoo plans to build an energy-efficient residential neighbourhood with 120 apartments on the site. A GSK Stockmann team led by partner Dr Martin Prothmann provided nyoo with transaction advice on the purchase of the redevelopment site in Schorndorf’s Weiler district. Following the partial demolition of the existing buildings and the planned removal of sealed surfaces, the site, which was previously used for commercial purposes, is to be redeveloped into an energy-efficient residential neighbourhood with around 120 apartments. The project is intended to support key urban development objectives of the town of Schorndorf. The seller is Oskar Frech GmbH + Co KG, which will continue to use its founding building located on the site. Construction is planned to commence at the start of 2028. Particular importance is placed on the sustainable development of the site, with heat pumps and photovoltaic systems forming an integral part of the energy concept. The design will also incorporate extensive green roofs to support the local microclimate. The plans are based on the KfW Efficiency House 40 standard, with the aim of ensuring stable operating and ancillary costs over the long term. Advisers of nyoo Real Estate GmbH at GSK Stockmann: Dr Martin Prothmann (lead, Real Estate Transactions & Investments), Pascal Franke, Jakob Haddad (both Real Estate Transactions & Investments), Kristina Marx, Nika Richard (both Real Estate Projects, Public Construction Law), Dr Mechtild-Maria Siebke (Finance) ### Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de Nyoo Real Estate (nyoo) is a subsidiary of the listed Instone Group, making it one of Germany's leading residential developers. We are shaping the future of intelligent residential construction – with innovative 360-degree solutions that can be implemented in serial production with maximum process reliability and with full cost, scheduling and quality guarantees for our customers. By consistently standardising and optimising the entire project development and construction process, we create needs-based living space throughout Germany from a single source – efficiently, sustainably and attractively. nyoo currently has around 55 employees at four locations. www.nyoo-by-instone.de

GSK Stockmann advised the Arsipa Group on its acquisition of the digital specialist Bloom. The acquisition of the Berlin-based health tech start-up is a key component of Arsipa’s digital strategy and will enable the group to expand its market leadership in occupational health and safety, while also creating the first digital-native occupational health and safety compliance platform in Germany and Austria. A GSK Stockmann team led by Berlin partner Robert Korndörfer provided the Arsipa Group with comprehensive legal advice on the transaction. The combination of personal on-site support throughout Germany and a powerful software platform has established a provider that now offers an all-in-one, end-to-end digital, hybrid and analogue solution for occupational health and safety that meets the needs of all customer groups. The Arsipa Group is a portfolio company specialising in occupational medicine, occupational safety, occupational psychology and environmental protection. It has approximately 850 employees across more than 60 locations in Germany and Austria and serves over 22,000 companies. Since 2021, Bloom Healthtech GmbH has been developing an AI-supported platform for the automation of occupational health and safety (OHS) compliance, supporting companies with the active, efficient and transparent implementation of complex legal requirements. Bloom integrates processes into existing systems, thereby reducing the manual workload for HR departments, and offers a digital, automated OHS compliance management solution. GSK Stockmann has a proven track record in providing expert advice on transactions in the healthcare sector, having previously advised Arsipa on its acquisition of the occupational healthcare providers Betriebsärzte Allgäu and Betriebsmedizin-23 GmbH in Munich. Contact: GSK STOCKMANN Robert Korndörfer Anton-Wilhelm-Amo-Str. 42 10117 Berlin T +49 30 203907 - 93 F +49 30 203907-44 [email protected]  Press Contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] Advisers of Arsipa at GSK Stockmann: Robert Korndörfer (lead, Partner, Corporate), Dr Jörg Kahler (Partner, IP/IT), Stephan Wachsmuth (Local Partner, Tax), Nicole Deparade (Local Partner, Employment Law), Clara López Hernando (Senior Associate, Corporate), Katrin Zukovskaja (Associate, Employment Law), Dr Maximilian Schnebbe (Associate, Data Protection) ###GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

Commercial law firm GSK Stockmann continues the strategic expansion of its Corporate team by welcoming Bernd Graßl as a partner at its Munich office with effect from 1 August 2025. The new addition highlights the firm’s leading position in European commercial law and will enhance its range of advisory expertise for listed companies and international cases, as well as in corporate litigation. Dr Bernd Graßl, formerly a partner at GLNS, has extensive expertise in stock corporation and capital markets law, public M&A and corporate law as well as in stock corporation and capital markets disputes and corporate litigation. His many years of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s growing Corporate team. As a trusted expert in his field, Bernd Graßl will help to further strengthen the firm’s 360-degree advisory approach. This means that clients will benefit from even more comprehensive, customised solutions both in Germany and at GSK Stockmann’s international offices in Luxembourg and London. Bernd Graßl will bring fresh dynamism to the team, particularly when it comes to supporting capital market companies and advising on complex corporate law issues and the particularities of legal disputes involving listed companies. “With Bernd Graßl on board, we are ideally positioned to advise and represent clients in the currently recovering stock market environment. His broad expertise and experience are a valuable addition to our Corporate team, both throughout Germany and internationally,” says Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division, commenting on the arrival of the new partner. “His proven track record in stock corporation and capital markets law, as well as in IPOs for tech companies, makes him a real asset for our clients and our team. The firm will also benefit greatly from his experience in corporate litigation.” “Bernd Graßl’s expertise will enable us to provide our clients with even more comprehensive and strategic support in complex corporate law disputes,” adds Dr Justus Jansen, Managing Partner at GSK Stockmann. “His expertise complements our existing knowledge perfectly and will help us to continue to strengthen our position in the area of corporate litigation. This will allow us to offer our clients an even broader spectrum of high-quality advice – both here in Germany and internationally.” Bernd Graßl is looking forward to his new role: “GSK Stockmann stands for legal advice of the highest quality, entrepreneurial foresight and a strong international network. I am looking forward to working with a highly motivated team to develop innovative, bespoke solutions for our clients, as well as expanding the firm’s range of services throughout Europe.” Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de

TopLegal – one of Italy’s leading legal publications – recognized GSK Stockmann as “Italian Desk independente dell’anno” (“Independent Italian Desk of the year”) at the TopLegal Awards 2024 in Milan. The TopLegal Awards were initiated in 2007 providing law and tax firms a platform to present their skills and quality in the context of advising and assisting clients – taking place on an annual basis. The criteria include client service, innovation, specific sector knowledge and client solutions. The TopLegal Awards reward both, teams and individual professionals. The full list of winners of the TopLegal Awards 2024 is available here. Valerio Scollo, Partner at GSK Stockmann and co-head of the GSK Desk Italy, says: “We are delighted that our work is recognized by the TopLegal Awards 2024 in the category “Italian Desk – independent law firm of the year”. Winning the award underlines GSK Stockmann’s ongoing growth and development of the firm’s international activities as a leading independent firm in Europe”. GSK Stockmann has bundled its many years of international activities into country desks – GSK Desks – to serve its clients’ global requirements, providing seamless German and Luxembourg law services out of its offices in Germany, Luxembourg and the UK.  

GSK Stockmann has provided comprehensive legal advice to L-Rea GmbH on the establishment of a joint venture with the BlueRock Group AG regarding L-Rea GmbH’s subsidiary Residea Immobilien Management GmbH. Since April, the BlueRock Group AG, based in Zurich and Berlin, holds a stake in Residea Immobilien Management GmbH as part of a joint venture. A team led by Berlin based partner and Corporate/M&A specialist Dr. Thomas Derlin provided comprehensive legal support to L-Rea GmbH regarding this strategic partnership with BlueRock Group AG, in particular in the negotiations and conclusion of the share purchase agreement and the joint venture agreement as well as related corporate and commercial law issues. Residea Immobilien Management GmbH is a fully integrated asset management company, managing a portfolio of several thousand residential and commercial units, primarily in Berlin. For the real estate investor and asset manager BlueRock Group AG, the participation secures access to qualified management capacities in the demanding Berlin real estate market. [caption id="attachment_48294" align="alignnone" width="300"] GSK Berlin[/caption] Advisers of L-Rea at GSK Stockmann: Dr Thomas Derlin, Dr Andreas C. Peters (both lead, both Corporate/M&A), Dominik Berka (Tax), Jan Kramer (Real Estate) Christina Lorf (Corporate/M&A) Advisers of Blue Rock Group: Heussen Rechtsanwaltsgesellschaft mbH: Jan Dittmann, Johannes Weidelener Notary: Heuking Contact: GSK STOCKMANN Dr Thomas Derlin Mohrenstrasse 42 10117 Berlin T +49 30 203907 - 0 F +49 30 203907-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de/en

GSK Stockmann provided Deka Immobilien with comprehensive advice on the leasing of approximately 21,300 square metres of office space in the “An den Brücken” property at Landsberger Strasse 84-90 in Munich to the E.ON Group. The lease was signed in February 2026, and the tenant will be able to move into the first section of the rented space from January 2027. Following the conclusion of this deal, the approximately 23,000 sqm of office space available in the six-storey building is once again fully let. For GSK Stockmann, this transaction is part of a long history of advising Deka in connection with the “An den Brücken” property. The firm originally advised Deka Immobilien on the purchase of the building back in 2014 and has provided ongoing asset management advice for the property ever since, including providing support with lease agreements and settling the previous tenancy with the FTI Group. “We are delighted to have supported Deka Immobilien in the successful conclusion of this lease. The fact that we have been entrusted with supporting the property from its initial acquisition through ongoing asset management to this significant lease agreement is a testament to the confidence that our clients have in our comprehensive real estate expertise. I would like to thank my team, Katharina Groche (Local Partner) and Bianca Luppert (Associate), who provided the lion’s share of the advice in this case,” says Monique Franke, Partner for Real Estate Investments & Asset Management at GSK Stockmann. Advisers of Deka Immobilien at GSK Stockmann: Monique Franke and Katharina Groche (both lead), Bianca Luppert (all Real Estate Investments & Asset Management) [caption id="attachment_56686" align="alignnone" width="300"] GSK München[/caption]   ### Contact: GSK STOCKMANN Monique Franke Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 661 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de

GSK Stockmann provided comprehensive legal advice on the sale of a majority stake in Deutsche Investment Kapitalverwaltung AG and other companies of the Deutsche Investment Group. The buyer is Deutsche Pfandbriefbank AG. The Deutsche Investment Group is a provider of asset and investment solutions for institutional investors in the residential and commercial property sector. The group has around 375 employees across seven locations in Germany and assets under management totalling over 3 billion euros. A GSK Stockmann team led by Hamburg-based partners Dennis Stenzel and Andreas Peters provided comprehensive advice on the sale. While advising on the transaction, the team was able to draw on one of GSK Stockmann’s core strengths, namely the seamless integration of corporate law expertise and regulatory knowledge across different teams and locations. Deutsche Pfandbriefbank AG (pbb), a leading European bank specialising in commercial real estate finance, is acquiring 89.9% of the regulated Deutsche Investment Kapitalverwaltung AG as well as other companies and majority shareholdings of the Deutsche Investment Group. The purchase price, including variable components, is in the mid-double-digit million euro range. Subject to customary closing conditions, including the necessary regulatory approvals, the transaction is expected to be completed in the first quarter of 2026. Advisers of the seller at GSK Stockmann: Dennis Stenzel (Real Estate Transactions & Investments), Dr Andreas C. Peters (joint lead, Corporate/M&A), Dr Philipp M. Kuhn (Employment Law); Associates: Lisa Gebhard (Real Estate Transactions & Investments), Marie Bogutzki (Investments & Finance), Sebastian Gerhards (Tax), Dr Johanna Baumann (M&A), Raphaela Guderian, Katrin Zukovskaja (both Employment Law), Louisa Hecker (Investments & Finance) Advisers of Deutsche Pfandbriefbank AG Hengeler Müller (comprehensive legal advice), Gleiss Lutz (employment law); Ritterwald Unternehmensberatung, Hystake Investment Partners. Contact: GSK STOCKMANN Dennis Stenzel/Dr Andreas Peters Neuer Wall 69 20354 Hamburg T +49 40 369703 - 0 F +49 40 369703-44 [email protected]/[email protected] Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de